View Author
scopus: 18937316500

Smith, W.C.S.

(Cairns Smith)


leprosy patient nerve study reaction nerve function impairment month trial group event treatment impairment registration intervention function outcome nerve damage health corticosteroids disability prednisolone analysis damage mb patients period follow-up result review type 1 reaction participant placebo incidence leprosy patients lepr rev pod interventions title issue int j lepr 2 years figure observation period randomised quality number cost-effectiveness type 1 reactions ulcer ravi 2004 effect control regimen therapy nicholls pg cohort placebo group duration remme 2006 type 2 reaction improvement type 2 reactions disease 6 months pb patients score author neuritis bangladesh effectiveness corticosteroid seboka programmes remme evidence seboka 1996 observation 6 months duration oxford university press table health care programmes consequence




4 Most Recent Publications

Potential effect of the world health organization's 2011-2015 global leprosy strategy on the prevalence of grade 2 disability: A trend analysis (Article)
Alberts, C.J. Smith, W.C.S. Meima, A. Wang, L. Richardus, J.H.
2011-07-01
Corticosteroids for treating nerve damage in leprosy. A Cochrane review. (Article)
Veen, N.H.J. van Nicholls, P.G. Smith, W.C.S. Richardus, J.H.
2009-06-02
Cost-effectiveness of interventions to prevent disability in leprosy: A systematic review (Article)
Veen, N.H.J. van McNamee, P. Richardus, J.H. Smith, W.C.S.
2009-02-20
Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up. (Article)
Richardus, J.H. Nicholls, P.G. Croft, R.P. Withington, S.G. Smith, W.C.S.
2004-04-01